Intraoperative Fluid Management Guided by Internal Jugular Vein on Postoperative Complications in Abdominal Surgeries
Launched by SUEZ CANAL UNIVERSITY · Jun 26, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to manage fluids given to patients during abdominal surgery to help reduce problems after the operation. Doctors will use a special method that looks at how the internal jugular vein (a large vein in the neck) changes with breathing to guide how much fluid is given during surgery. The goal is to see if this approach can lower complications after surgery, shorten hospital stays, and improve overall recovery compared to the usual fluid management methods.
People who may join the study are adults between 20 and 70 years old who are generally healthy (with no serious heart, kidney, or lung diseases) and are scheduled for abdominal surgery under general anesthesia. Participants will be randomly placed into two groups: one group will have fluids managed using the vein-monitoring method, and the other will receive standard care. During and after surgery, the research team will track things like complications, blood pressure changes, use of medications to support blood pressure, and how much fluid is given. This study is not yet recruiting participants but aims to find a safer and more effective way to care for patients during abdominal surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients' American Society of Anesthesiologists physical status (ASA) is I and II.
- • 2. The target age group is 20 to 70 years old.
- • 3. Patients scheduled for abdominal surgery under general anesthesia with normal renal function.
- Exclusion Criteria:
- • 1. Refusal of the procedure or participation in the study.
- • 2. Coagulopathy.
- • 3. Pre-existing cardiac, renal, and respiratory diseases. 4-Internal jugular vein thrombosis
About Suez Canal University
Suez Canal University is a distinguished academic institution dedicated to advancing medical research and education in the region. As a clinical trial sponsor, the university focuses on conducting innovative studies that aim to enhance patient care and outcomes. Leveraging its strong network of healthcare professionals and state-of-the-art facilities, Suez Canal University fosters collaboration between researchers and clinicians to explore new therapeutic approaches and validate clinical practices. Committed to ethical standards and scientific rigor, the university plays a pivotal role in contributing to the global body of medical knowledge and improving healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ismailia, , Egypt
Patients applied
Trial Officials
Mohammad E Salama, MD
Principal Investigator
Suez canal university hospitals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported